These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 31773463
1. Source of oseltamivir resistance due to single E119D and double E119D/H274Y mutations in pdm09H1N1 influenza neuraminidase. Hanpaibool C, Leelawiwat M, Takahashi K, Rungrotmongkol T. J Comput Aided Mol Des; 2020 Jan; 34(1):27-37. PubMed ID: 31773463 [Abstract] [Full Text] [Related]
2. Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors. Baek YH, Song MS, Lee EY, Kim YI, Kim EH, Park SJ, Park KJ, Kwon HI, Pascua PN, Lim GJ, Kim S, Yoon SW, Kim MH, Webby RJ, Choi YK. J Virol; 2015 Jan; 89(1):287-99. PubMed ID: 25320319 [Abstract] [Full Text] [Related]
4. E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient. L'Huillier AG, Abed Y, Petty TJ, Cordey S, Thomas Y, Bouhy X, Schibler M, Simon A, Chalandon Y, van Delden C, Zdobnov E, Boquete-Suter P, Boivin G, Kaiser L. J Infect Dis; 2015 Dec 01; 212(11):1726-34. PubMed ID: 25985905 [Abstract] [Full Text] [Related]
6. Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus. Woods CJ, Malaisree M, Pattarapongdilok N, Sompornpisut P, Hannongbua S, Mulholland AJ. Biochemistry; 2012 May 29; 51(21):4364-75. PubMed ID: 22574858 [Abstract] [Full Text] [Related]
10. Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors. Pizzorno A, Bouhy X, Abed Y, Boivin G. J Infect Dis; 2011 Jan 01; 203(1):25-31. PubMed ID: 21148493 [Abstract] [Full Text] [Related]
11. H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and structural analysis. van der Vries E, Collins PJ, Vachieri SG, Xiong X, Liu J, Walker PA, Haire LF, Hay AJ, Schutten M, Osterhaus AD, Martin SR, Boucher CA, Skehel JJ, Gamblin SJ. PLoS Pathog; 2012 Sep 01; 8(9):e1002914. PubMed ID: 23028314 [Abstract] [Full Text] [Related]
12. Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir. Park JW, Jo WH. J Chem Inf Model; 2009 Dec 01; 49(12):2735-41. PubMed ID: 19957991 [Abstract] [Full Text] [Related]
13. An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness. Kwon JJ, Choi WS, Jeong JH, Kim EH, Lee OJ, Yoon SW, Hwang J, Webby RJ, Govorkova EA, Choi YK, Baek YH, Song MS. J Gen Virol; 2018 Mar 01; 99(3):292-302. PubMed ID: 29493493 [Abstract] [Full Text] [Related]
14. The E119D neuraminidase mutation identified in a multidrug-resistant influenza A(H1N1)pdm09 isolate severely alters viral fitness in vitro and in animal models. Abed Y, Bouhy X, L'Huillier AG, Rhéaume C, Pizzorno A, Retamal M, Fage C, Dubé K, Joly MH, Beaulieu E, Mallett C, Kaiser L, Boivin G. Antiviral Res; 2016 Aug 01; 132():6-12. PubMed ID: 27185624 [Abstract] [Full Text] [Related]
16. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season. Baranovich T, Saito R, Suzuki Y, Zaraket H, Dapat C, Caperig-Dapat I, Oguma T, Shabana II, Saito T, Suzuki H, Japanese Influenza Collaborative Study Group. J Clin Virol; 2010 Jan 01; 47(1):23-8. PubMed ID: 19962344 [Abstract] [Full Text] [Related]
19. Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs. Correia V, Santos LA, Gíria M, Almeida-Santos MM, Rebelo-de-Andrade H. J Med Virol; 2015 Jan 01; 87(1):45-56. PubMed ID: 25042157 [Abstract] [Full Text] [Related]